Amino acid deprivation induces AKT activation by inducing GCN2/ATF4/REDD1 axis

Hyeon-Ok Jin1, Sung-Eun Hong2, Ji-Young Kim2

  • 1KIRAMS Radiation Biobank, Korea Institute of Radiological and Medical Sciences, Seoul, 01812, Republic of Korea. hyeonok@kirams.re.kr.

Cell Death & Disease
|December 4, 2021
PubMed

Insights

Amino acid deprivation activates AKT signaling in non-small cell lung cancer (NSCLC) via the GCN2/ATF4/REDD1 pathway. REDD1 is crucial for this activation and sensitizes NSCLC cells to radiotherapy when glutamine is deprived.

Area of Science:

  • Cancer Biology
  • Molecular Oncology
  • Cellular Metabolism

Background:

  • Amino acid availability is critical for cell survival and is sensed by key signaling pathways like GCN2 and mTORC1.
  • The precise mechanisms linking amino acid sensing to cancer cell survival, particularly AKT activation, remain incompletely understood.

Purpose of the Study:

  • To investigate the role of specific amino acid deprivation in activating AKT signaling in non-small cell lung cancer (NSCLC) cells.
  • To elucidate the molecular axis responsible for AKT activation under conditions of low amino acid availability.

Main Methods:

  • Utilized non-small cell lung cancer (NSCLC) cell lines.
  • Deprived cells of individual amino acids to assess effects on AKT activation.
  • Employed CRISPR-Cas9 gene editing to create REDD1-knockout cells.
  • Evaluated the impact of REDD1 knockout on AKT activation and radiosensitivity under amino acid deprivation.

Main Results:

  • Deprivation of glutamine, arginine, methionine, and lysine induced AKT activation in NSCLC cells.
  • AKT activation was mediated by the GCN2/ATF4/REDD1 axis, leading to mTORC2 activation.
  • REDD1 knockout abrogated AKT activation upon amino acid deprivation.
  • REDD1-deficient cells showed increased sensitivity to radiotherapy when cultured under glutamine deprivation.

Conclusions:

  • The GCN2/ATF4/REDD1 axis plays a pivotal role in promoting cancer cell survival signals in response to amino acid deprivation.
  • Targeting the REDD1-mediated pathway could represent a novel therapeutic strategy for NSCLC, potentially enhancing radiotherapy efficacy.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.9K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.0K